Umbilical cord blood–derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?


Like Comment
Related Content

VOLUME 115, ISSUE 2, P336-337


Cristina Subiran, M.Sc., Stine Gry Kristensen, Ph.D., Claus Yding Andersen, D.M.Sc.


Reflections on "Comparison of different sources of platelet-rich plasma as treatment option for infertility-causing endometrial pathologies" by de Miguel-Gómez et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.